Nonlinear Association Between Serum Uric Acid Levels and Mortality in Maintenance Hemodialysis Patients: A Retrospective Study From the Beijing Hemodialysis Quality Control and Improvement Center

BACKGROUND: To investigate the association between serum uric acid levels and the risks of all-cause and cardiovascular mortality in patients undergoing maintenance hemodialysis. METHODS: Patients receiving maintenance hemodialysis registered in 2014 in the Beijing Blood Purification Quality Control and Improvement Center database were included. Patients were stratified into low (≤ 344 μmol/L), intermediate (344-464 μmol/L), and high (> 464 μmol/L) serum uric acid groups. Propensity score matching (1:1:1) was performed using age, sex, diabetes, and dialysis vintage. Survival was analyzed using Kaplan-Meier curves and the log-rank test. Cox proportional hazards models and restricted cubic spline analyses were applied to evaluate the associations between serum uric acid levels and all-cause and cardiovascular death. RESULTS: We enrolled 2070 patients in three matched groups (n = 690 per group). The median follow-up was 64.0 (interquartile range, 31.1-72.0) months. All-cause death occurred in 292/690 (42.3%), 122/690 (17.7%), and 210/690 (30.4%) patients in the low-, intermediate-, and high-serum uric acid groups, respectively. After adjusting for multiple factors, the intermediate serum uric acid group had better survival than the low- (hazard ratio, 1.82; 95% confidence interval [95% CI], 1.41-2.34; p < 0.001) and high-serum uric acid groups (hazard ratio, 2.13; 95% CI, 1.64-2.76; p < 0.001). The pattern of cardiovascular death was consistent with that of all-cause mortality, showing higher risks in both the low- and high-serum uric acid groups compared with the intermediate-serum uric acid group. Further restricted cubic spline analyses suggested a U-shaped association between serum uric acid levels and the risks of all-cause and cardiovascular mortality, with the lowest mortality risk observed at serum uric acid levels of approximately 388-420 μmol/L. CONCLUSION: Serum uric acid exhibited a U-shaped association with the risks of all-cause and cardiovascular death in patients undergoing maintenance hemodialysis. Both excessively low and high serum uric acid levels were associated with increased mortality risk.

Authors

Institutions

Publication Details

Journal
Hemodialysis International
Published
2026-06-28
DOI
https://doi.org/10.1111/hdi.70105
Primary Topic
Gout, Hyperuricemia, Uric Acid
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Nonlinear Association Between Serum Uric Acid Levels and Mortality in Maintenance Hemodialysis Patients: A Retrospective Study From the Beijing Hemodialysis Quality Control and Improvement Center

Zongli Diao, Wenhu Liu, Wang Guo, Huixian Zhang et al.
Hemodialysis International
Gout, Hyperuricemia, Uric Acid
article

Nonlinear Association Between Serum Uric Acid Levels and Mortality in Maintenance Hemodialysis Patients: A Retrospective Study From the Beijing Hemodialysis Quality Control and Improvement Center

Zongli Diao, Wenhu Liu, Wang Guo, Huixian Zhang, Jing Liu
article en

Abstract

BACKGROUND: To investigate the association between serum uric acid levels and the risks of all-cause and cardiovascular mortality in patients undergoing maintenance hemodialysis. METHODS: Patients receiving maintenance hemodialysis registered in 2014 in the Beijing Blood Purification Quality Control and Improvement Center database were included. Patients were stratified into low (≤ 344 μmol/L), intermediate (344-464 μmol/L), and high (> 464 μmol/L) serum uric acid groups. Propensity score matching (1:1:1) was performed using age, sex, diabetes, and dialysis vintage. Survival was analyzed using Kaplan-Meier curves and the log-rank test. Cox proportional hazards models and restricted cubic spline analyses were applied to evaluate the associations between serum uric acid levels and all-cause and cardiovascular death. RESULTS: We enrolled 2070 patients in three matched groups (n = 690 per group). The median follow-up was 64.0 (interquartile range, 31.1-72.0) months. All-cause death occurred in 292/690 (42.3%), 122/690 (17.7%), and 210/690 (30.4%) patients in the low-, intermediate-, and high-serum uric acid groups, respectively. After adjusting for multiple factors, the intermediate serum uric acid group had better survival than the low- (hazard ratio, 1.82; 95% confidence interval [95% CI], 1.41-2.34; p < 0.001) and high-serum uric acid groups (hazard ratio, 2.13; 95% CI, 1.64-2.76; p < 0.001). The pattern of cardiovascular death was consistent with that of all-cause mortality, showing higher risks in both the low- and high-serum uric acid groups compared with the intermediate-serum uric acid group. Further restricted cubic spline analyses suggested a U-shaped association between serum uric acid levels and the risks of all-cause and cardiovascular mortality, with the lowest mortality risk observed at serum uric acid levels of approximately 388-420 μmol/L. CONCLUSION: Serum uric acid exhibited a U-shaped association with the risks of all-cause and cardiovascular death in patients undergoing maintenance hemodialysis. Both excessively low and high serum uric acid levels were associated with increased mortality risk.

Hemodialysis International
Capital Medical University (CN)
Good health and well-being
Openalex Percentile: Top 7%
Gout, Hyperuricemia, Uric Acid
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.